Vijaya Diagnostic Centre Limited has announced the resignation of a key executive, marking a significant change in its leadership team.

Executive Departure

V. Siva Rama Raju Vegesna, Vice President of Operations at Vijaya Diagnostic Centre, has tendered his resignation citing personal reasons. The company has accepted his resignation, which will take effect on November 8, 2025, at the close of business hours.

Tenure and Contributions

Mr. Vegesna has been an integral part of Vijaya Diagnostic Centre for over six years, serving as a member of the Management Team at the Group Level. During his tenure, he played a crucial role in several key areas:

• Strengthening the company's investor relations
• Supporting strategic initiatives
• Assisting in the company's expansion into new markets

Company's Statement

In an official statement, Vijaya Diagnostic Centre expressed its appreciation for Mr. Vegesna's service:

"The Board and Management place on record their sincere appreciation of his dedicated service, professional acumen, and valuable guidance extended to the organization over the years. The Company conveys its best wishes to him for good health, happiness, and continued success in all his future endeavours."

Transition Period

With the announcement made well in advance, Vijaya Diagnostic Centre has approximately a year to manage the transition. This period may allow the company to search for a suitable replacement or restructure the role as needed.

Market Impact

As of now, the company has not announced any immediate plans for succession or the potential impact on its operations. Investors and stakeholders will likely be watching closely to see how Vijaya Diagnostic Centre manages this transition in its executive team.

Stakeholders are advised to monitor further announcements from the company regarding any updates on this matter or potential changes in the operational structure.

The proposed merger between Vijaya Diagnostic Centre Limited and Medinova Diagnostic Services Limited has reached a crucial juncture as the National Company Law Tribunal (NCLT) in Hyderabad has reserved its order on the matter.

Merger Proceedings

The Hon'ble NCLT Hyderabad Bench, during a hearing, reserved its decision on the Scheme of Amalgamation filed under Sections 230 to 232 of the Companies Act, 2013. This scheme proposes the amalgamation of Medinova Diagnostic Services Limited (the Transferor Company) with Vijaya Diagnostic Centre Limited (the Transferee Company), along with their respective shareholders and creditors.

Key Details of the Proposed Merger

Current Status

Vijaya Diagnostic Centre Limited, in its regulatory filing, stated that the attendance-cum-order sheet recording the "Orders Reserved" status has been uploaded on the NCLT website. The company is awaiting the certified true copy of the order, which will be submitted to the stock exchanges upon receipt.

Market Implications

The postponement of the ruling has left stakeholders in a state of anticipation. Both Vijaya Diagnostic Centre and Medinova Diagnostic Services are closely watching the proceedings, as the outcome will significantly impact their future operations and market positioning in the diagnostic services sector.

Next Steps

Investors and market observers are advised to keep a close watch on further announcements from both companies and the NCLT. The final order, once pronounced, will provide clarity on the merger's fate and its implications for the diagnostic services landscape in India.

As the diagnostic sector continues to evolve, especially in the wake of increased health awareness, the outcome of this merger could potentially reshape market dynamics and service offerings in the industry.